Literature DB >> 20047628

Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report.

Gaurav Kapur1, Maheen Ahmed, Cynthia Pan, Mark Mitsnefes, Myra Chiang, Tej K Mattoo.   

Abstract

According to the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents, stage 1 hypertension is often primary in origin and associated with overweight. In contrast, stage 2 hypertension is more often secondary in origin and, hence, requires more extensive evaluation according to task force recommendations. The objective of this retrospective study was to evaluate whether the presence of stage 1 hypertension in overweight pediatric patients precludes workup for secondary hypertension (SH). This study included children (5-18 years) with hypertension (defined and staged per task force recommendations) referred to 4 pediatric nephrology centers in the Midwest region. Of the 246 referred patients, 166 patients with primary hypertension (PH) and SH were included for body mass index and hypertension stage analysis. The study revealed no significant differences in the mean age at diagnosis (PH, 13.1+/-3.1 years; SH, 12.4+/-3.8 years), distribution of overweight (PH, 89.4% BMI >85th percentile; SH, 80% BMI >85th percentile), and stage 1 (PH, 45%; SH, 40%) or 2 hypertensive (PH,55%; SH, 60%) children between PH vs SH. Overweight and presence of stage 1 hypertension should not preclude evaluation for SH.

Entities:  

Mesh:

Year:  2010        PMID: 20047628      PMCID: PMC8672976          DOI: 10.1111/j.1751-7176.2009.00195.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Pediatric antecedents of adult cardiovascular disease--awareness and intervention.

Authors:  Julie R Ingelfinger
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 3.  Rationale to study the early natural history of heart disease: the Bogalusa Heart Study.

Authors:  G S Berenson; W A Wattigney; W Bao; S R Srinivasan; B Radhakrishnamurthy
Journal:  Am J Med Sci       Date:  1995-12       Impact factor: 2.378

Review 4.  Hypertension in children.

Authors:  A R Sinaiko
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

Review 5.  What's new in pediatric hypertension?

Authors:  J T Flynn
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

6.  Prevalence, persistence, and clinical significance of masked hypertension in youth.

Authors:  Empar Lurbe; Isabel Torro; Vicente Alvarez; Tim Nawrot; Rafael Paya; Josep Redon; Jan A Staessen
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

7.  Characteristics of children with primary hypertension seen at a referral center.

Authors:  Joseph T Flynn; Michael H Alderman
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

8.  Inaccuracy in pediatric outpatient blood pressure measurement.

Authors:  Amber Podoll; Michelle Grenier; Beth Croix; Daniel I Feig
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

9.  Comparison of ambulatory blood pressure and Task Force criteria to identify pediatric hypertension.

Authors:  Leila N Díaz; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-11-23       Impact factor: 3.714

10.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

Authors:  G J Schwartz; L P Brion; A Spitzer
Journal:  Pediatr Clin North Am       Date:  1987-06       Impact factor: 3.278

View more
  15 in total

Review 1.  Autonomic nervous system dysregulation in pediatric hypertension.

Authors:  Janusz Feber; Marcel Ruzicka; Pavel Geier; Mieczyslaw Litwin
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

2.  Primary versus secondary hypertension in children followed up at an outpatient tertiary unit.

Authors:  Romina S Gomes; Isabel G Quirino; Regina M Pereira; Breno M Vitor; Alysson F Leite; Eduardo A Oliveira; Ana Cristina Simões e Silva
Journal:  Pediatr Nephrol       Date:  2010-12-21       Impact factor: 3.714

Review 3.  Updated Guideline May Improve the Recognition and Diagnosis of Hypertension in Children and Adolescents; Review of the 2017 AAP Blood Pressure Clinical Practice Guideline.

Authors:  Janis M Dionne
Journal:  Curr Hypertens Rep       Date:  2017-10-16       Impact factor: 5.369

Review 4.  Evaluation and Management of Stage 2 Hypertension in Pediatric Patients.

Authors:  Yosuke Miyashita; Coral Hanevold
Journal:  Curr Hypertens Rep       Date:  2018-07-06       Impact factor: 5.369

Review 5.  Evaluation of hypertension in children.

Authors:  Gaurav Kapur; Rossana Baracco
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

6.  Diagnosis and management of white-coat hypertension in children and adolescents: A Midwest Pediatric Nephrology Consortium study.

Authors:  Yosuke Miyashita; Joseph T Flynn; Coral D Hanevold
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-23       Impact factor: 3.738

Review 7.  Treatment of obesity-related hypertension in children and adolescents.

Authors:  Susan M Halbach; Joseph Flynn
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 8.  Pharmacologic Management of Pediatric Hypertension.

Authors:  Jason Misurac; Kristen R Nichols; Amy C Wilson
Journal:  Paediatr Drugs       Date:  2016-02       Impact factor: 3.022

Review 9.  The changing face of pediatric hypertension in the era of the childhood obesity epidemic.

Authors:  Joseph Flynn
Journal:  Pediatr Nephrol       Date:  2012-11-09       Impact factor: 3.714

10.  Prediction of primary vs secondary hypertension in children.

Authors:  Rossana Baracco; Gaurav Kapur; Tej Mattoo; Amrish Jain; Rudolph Valentini; Maheen Ahmed; Ronald Thomas
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.